2139
Protease inhibitors (ritonavir and saquinavir) were added to the treatment and the patient developed progressive ataxia related to carbamazepine toxicity.
 the patient: Subject; progressive ataxia related to carbamazepine toxicity: Effect; Protease inhibitors (ritonavir and saquinavir) were added to the treatment: Treatment; carbamazepine: Treatment; carbamazepine: Treatment.Drug; Protease inhibitors: Treatment.Drug; Protease inhibitors: Combination.Drug; carbamazepine: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 the patient: Subject; progressive ataxia related to carbamazepine toxicity: Effect; Protease inhibitors (ritonavir and saquinavir) were added to the treatment: Treatment; carbamazepine: Treatment; carbamazepine: Treatment.Drug; Protease inhibitors: Treatment.Drug; Protease inhibitors: Combination.Drug; carbamazepine: Combination.Drug